Fonte: Investigative Ophthalmology and Visual Science. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XU, Hui et al. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EUA: Protection is independent of IL-10-inducing activity. Investigative Ophthalmology and Visual Science, v. 40, p. 942-950, 1999Tradução . . Acesso em: 28 nov. 2025.APA
Xu, H., Strassmann, G., Chan, C. -C., Rizzo, L. V., Silver, P. B., Wiggert, B., & Caspi, R. R. (1999). Protective effect of the type IV phosphodiesterase inhibitor rolipram in EUA: Protection is independent of IL-10-inducing activity. Investigative Ophthalmology and Visual Science, 40, 942-950.NLM
Xu H, Strassmann G, Chan C-C, Rizzo LV, Silver PB, Wiggert B, Caspi RR. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EUA: Protection is independent of IL-10-inducing activity. Investigative Ophthalmology and Visual Science. 1999 ; 40 942-950.[citado 2025 nov. 28 ]Vancouver
Xu H, Strassmann G, Chan C-C, Rizzo LV, Silver PB, Wiggert B, Caspi RR. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EUA: Protection is independent of IL-10-inducing activity. Investigative Ophthalmology and Visual Science. 1999 ; 40 942-950.[citado 2025 nov. 28 ]
